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To determine prevalence and genetic structures of new 
serotype  6D  strains  of  pneumococci,  we  examined  iso-
lates from diverse clinical specimens in South Korea dur-
ing 1991–2008. Fourteen serotype 6D strains accounted 
for 10.4% of serogroup 6 pneumococci from blood, sputum, 
nasopharynx, and throat samples. Serotype 6D strains con-
sisted of 3 sequence types. 
S
treptococcus pneumoniae is a common cause of inva-
sive infection in infants, children, and adults. The poly-
saccharide capsule of S. pneumoniae is the major virulence 
factor that protects the organism from host phagocytosis (1). 
Recently, 2 new serotypes of serogroup 6 pneumococci, 6C 
and 6D, were genetically and biochemically characterized 
(2,3). Serotype 6C was identified in 2007 on the basis of its 
distinct binding patterns with 2 monoclonal antibodies; se-
rotype 6C had previously been typed as 6A according to the 
standard quellung reaction. Serotype 6C produces glucose 
in the place of galactose in the 6A capsular polysaccharide 
and has the wciNβ gene, which is ≈200 bp shorter than the 
corresponding wciN gene in 6A (2,4). After the discovery 
and characterization of 6C through genetic and biochemi-
cal studies, a new experimental serotype, 6X1 (later named 
6D), was created by mutating the critical nucleotide in the 
wciP gene of the 6C capsule gene locus or by inserting the 
wciNβ gene into the 6B capsule gene locus (3). However, 
this putative serotype, 6D was thought to not exist in nature 
until recently, when 2 studies found 6D strains in nasopha-
ryngeal aspirates from children in Fiji during 2004–2007 
(5)  and  in  2  nasopharyngeal  aspirates  from  children  in 
South Korea in 2008 (6). Although serotype 6C has only 
recently been described, several studies indicate that sero-
type 6C pneumococci have been circulating in many coun-
tries, including the United States, the Netherlands, Austra-
lia, Israel, and South Africa (7–10). However, reports of 
naturally occurring serotype 6D pneumococci are limited.
We investigated the prevalence of serotypes 6C and 
6D in 2 collections of pneumococci isolated from clinical 
specimens in South Korea. We compared the genetic diver-
sity and antimicrobial drug susceptibility patterns of the 4 
serotypes, 6A, 6B, 6C, and 6D.
The Study
Of the 2 collections of pneumococcal isolates, the first 
consisted of 587 clinical specimens obtained from infants 
and children at Seoul National University Children’s Hos-
pital, Seoul, South Korea, from May 1991 through May 
2008. The second collection consisted of 225 clinical speci-
mens obtained from adults at 2 participating hospitals in 
Seoul from March 2004 through August 2007. When >1 
isolate was recovered from the same person, only the ini-
tial isolate was included in the study. From these 2 sample 
collections (n = 812), we redetermined serotypes for 134 
isolates previously assigned to serogroup 6. 
Serotyping was performed by using the quellung reac-
tion with antiserum for serogroup 6, factor 6b, and factor 
6c (Statens Serum Institute, Copenhagen, Denmark). To 
assign serotypes 6C and 6D, we screened all strains for 
wciNβ and wciP6B by using 2 simplex PCRs and subsequent 
sequencing analysis. The wciN gene was amplified with 
the forward primer (5106) 5′-TAC CAT GCA GGG TGG 
AAT GT-3′ and the reverse primer (3101) 5′-CCA TCC 
TTC GAG TAT TGC-3′, resulting in product sizes of 1.8 
kb for serotypes 6C and 6D for the wciNβ gene (2). The 
wciP gene was amplified by using the forward primer 5′-
AAT TTG TAT TTT ATT CAT GCC TAT ATC TGG -3′ 
and the reverse primer 5′-TTA GCG GAG ATA ATT TAA 
AAT GAT GAC TA-3′ (11). Presence of wciNβ and wciP6B 
was confirmed by sequencing analysis. A characteristic of 
6B wciP is the presence of an A at nucleotide position 584 
(according to the sequence of wciP [12]), which creates a 
codon for asparagine at residue 195 of the 6B wciP pro-
tein. Antimicrobial drug susceptibility testing, multilocus 
sequence typing (MLST), and eBURST analyses were per-
formed as described (13).
Capsular swelling reactions indicated 63 serotype 6A 
and 61 serotype 6B strains. However, 10 strains were not 
distinguished by the standard method (quellung reaction) 
because they reacted with both factors, 6b and 6c. Sequenc-
ing analysis showed that 6 serotype 6A strains were sero-
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of wciP6B. Subsequently, 4 serotype 6B strains and 10 un-
distinguished strains were identified as serotype 6D on the 
basis of the presence of wciNβ and wciP6B. 
Serotypes tested by using the molecular method were 
6A (n = 53, 39.6%), 6B (n = 61, 45.5%), 6C (n = 6, 4.5%), 
and 6D (n = 14, 10.4%). The earliest recovery of a serotype 
6D isolate was in 1996, and the earliest recovery of a sero-
type 6C isolate was in 1993. Two serotype 6D strains were 
obtained from adults, and the remaining 12 strains were 
obtained from infants or children. Sources of serotype 6D 
isolates were blood (n = 5), sputum (n = 6), nasopharynx (n 
= 2), and throat (n = 1) specimens (Table). All serogroup 
6 isolates except a 6C strain showed multidrug resistance 
to at least 3 classes of antimicrobial drugs. According to 
MLST, 3 sequence types (STs) were found in serotype 6D 
pneumococci (ST189 [n = 7], ST3171 [n = 4], and ST282 
[n = 3]), which fell into 2 clonal complexes according to 
eBURST analysis (Figure). ST189 and ST282 were closely 
related to clonal complex 81, which clustered with serotype 
6A strains. All 4 ST3171 strains were isolated from blood. 
Each ST exhibited distinct antimicrobial drug susceptibil-
ity patterns and genes for macrolide resistance (Table).
Conclusions
We  identified  14  naturally  occurring  serotype  6D 
strains  among  134  serogroup  6  pneumococci  collected 
from  diverse  clinical  specimens  in  South  Korea  during 
1991–2008.  The  prevalence  rate  of  serotype  6D  among 
serogroup 6 isolates was 10.4%, slightly higher than that 
of serotype 6C (4.5%). Although serotype 6D was only 
recently  discovered,  we  demonstrated  that  serotype  6D 
strains have been circulating since at least 1996. Serotype 
6D was identified from various clinical sources, including 
blood, sputum, throat swab, and nasopharynx specimens, 
contrasting with findings of 2 previous studies (5,6). 
The genetic structures of serotype 6D pneumococci in 
the MLST database (www.mlst.net) were single isolates of 
ST4241 (Australia); ST982, ST4190, ST5085, and ST5086 
(China); and 2 isolates of ST282 (South Korea). Of those, 
3 strains from China (ST982, ST5085, and ST5086) were 
closely related to the ST3171 strain from South Korea. This 
cluster of serotype 6D strains was associated with serotype 
6A and 6B isolates from 3 countries in Asia. A single iso-
late of ST4241 was related to STs associated mostly with 
serotype 6B, but the ST4170 strain did not seem to be linked 
to other STs. This study demonstrated that 7 serotype 6D 
strains of ST189 and 3 serotype 6D strains of ST282 were 
related to clonal complex 81, which had previously been as-
sociated with only serotype 6A isolated from South Korea. 
However, this clonal complex also included several STs 
associated with many other global serotypes, such as 23F, 
19F, and 19A. Although the mechanism is not completely 
clear, available data indicate that capsular switching from 
serotypes 6A, 23F, 19F, or 19A to serotype 6D is possible; 
this switching could occur in addition to replacement of 
the wciNβ gene into the 6B capsule gene locus. A previous 
study indicated capsular switching as the possible event for 
formation of serotype 6C isolates (14).
In a recent study, factor 6d antiserum was validated for 
accurate serotyping of 6C (10) and is now commercially 
available, but antiserum for detection of 6D has not yet 
been developed. Further studies will be required to inves-
tigate the prevalence and genetic relatedness of serotype 
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Table. Genetic structures and phenotypes of 14 strains of Streptococcus pneumoniae serotype 6D, Seoul, South Korea* 
CC or ST and year 
of isolation  Patient age  Sample source 
MIC, ȝg/mL  Macrolide resistance gene 
Penicillin  Cefotaxime  mefA  ermB 
CC81         
  ST189             
    2000  5 y  Throat swab  1.50  0.75  Present  Absent 
    2004  81 y  Sputum  2.00  1.00  Present  Absent 
    2006  1 y  Sputum  1.50  1.00  Present  Absent 
    2006  2 y  Sputum  1.00  0.75  Present  Absent 
    2007  5 y  Sputum  1.50  0.75  Present  Absent 
    2007  6 y  Nasopharynx  1.50  0.75  Present  Absent 
    2007  73 y  Blood  2.00  1.00  Present  Absent 
ST282         
  2004  4 mo  Sputum  1.50  0.75  Present Absent
  2005  8 mo  Nasopharynx  1.50  0.75  Present  Absent 
  2005  9 mo  Sputum  1.50  0.75  Present  Absent 
ST3171             
1996  1 y  Blood  0.06  0.05  Absent  Present 
1997  3 y  Blood  0.06  0.50  Absent  Present 
1997  14 y  Blood  0.06  0.50  Absent  Present 
1997  15 y  Blood  0.06  0.50  Absent  Present 
*CC, clonal complex; ST, sequence type. Antimicrobial drug susceptibility testing, detection of mefA/ermB, multilocus sequence typing, and eBURST 
analyses were performed as described (13). All strains were resistant to at least 3 antimicrobial drug classes. Streptococcus pneumoniae Serotype 6D, South Korea
6D pneumococci in different countries and to evaluate the 
effect of pneumococcal conjugate vaccine on serotype dis-
tribution.
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Figure.  eBURST  analysis  of  134  strains  of 
Streptococcus  pneumoniae  serogroup  6. 
Serotypes are indicated in parentheses. Circle 
size correlates with number of strains of each 
sequence  type.  Blue  circles  indicate  predicted 
founders  (original  sequence  types  within  the 
cluster). Serotype 6D is shown in red, serotype 
6C in blue.
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